Caxton Associates (UK)’s Axcelis ACLS Stock Holding History

Caxton Associates (UK)’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-60,941	Closed	-$3.03M	–	676
2025 Q1	$3.03M	Buy	+60,941	New	+$3.85M	0.11%	86

Other funds holding ACLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Caxton Associates (UK)'s ACLS Position: Q2 2025 in Review

Caxton Associates (UK) sold out of Axcelis (ACLS) in Q2 2025, closing a stake of 60,941 shares — an estimated $3.03M sold.

Caxton Associates (UK) first reported a position in ACLS in Q1 2025 and held it in 1 quarter. The position peaked at $3.03M in Q1 2025. 328 funds tracked by Wall St. Rank hold ACLS as of Q2 2025.

Caxton Associates (UK) reported no remaining Axcelis position as of Q2 2025 after selling out during the quarter.
Caxton Associates (UK) sold 60,941 Axcelis shares in Q2 2025, an estimated $3.03M.
Caxton Associates (UK) first reported a position in Axcelis in Q1 2025 and held it in 1 quarter.
Caxton Associates (UK)'s Axcelis position peaked at $3.03M in Q1 2025.
328 funds tracked by Wall St. Rank held Axcelis as of Q2 2025.

Based on Caxton Associates (UK)'s 13F filing for Q2 2025, filed 15 Aug 2025.